Immuron Ltd ADR

Immuron Ltd ADR EBIT per Employee

The EBIT per Employee of Immuron Ltd ADR (IMRN) as of Nov 11, 2026 is -579,000.00 USD. In the previous year, EBIT per Employee was -464,770.29 USD — a change of 24.58% (lower).

EBIT per Employee

-579,000.00USD

YoY

24.58%

Last updated:

EBIT per Employee of Immuron Ltd ADR is 2026 -579,000.00 USD. EBIT per Employee of Immuron Ltd ADR was 2025 -464,770.29 USD. It decreases by 24.58% lower compared to the previous year.

The Immuron Ltd ADR EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2019
-404,933.10 USD
Jan 1, 2020
-253,659.08 USD
Jan 1, 2021
-728,729.96 USD
Jan 1, 2022
-249,567.11 USD
Jan 1, 2023
-310,351.75 USD
Jan 1, 2024
-504,474.34 USD
Jan 1, 2025
-464,770.29 USD
Jan 1, 2026
-579,000.00 USD
The Immuron Ltd ADR EBIT per Employee history
YEAREBIT per EmployeeYoY
-579,000.00USD+24.58%
-464,770.29USD-7.87%
-504,474.34USD+62.55%
-310,351.75USD+24.36%
-249,567.11USD-65.75%
-728,729.96USD+187.29%
-253,659.08USD-37.36%
-404,933.10USD+43.42%
-282,341.19USD-61.30%
-729,531.25USD+1.54%
-718,501.75USD+93.08%
-372,119.19USD0.00%
-372,119.19USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Immuron Ltd ADR Stock analysis

What does Immuron Ltd ADR do? Immuron Ltd ADR is a biopharmaceutical company listed on the US market in 2017, operating from Carlton. The firm engages in the research, development, and commercialization of polyclonal antibodies across Australia, the United States, and Canada. It operates through Research and Development and Hyper-immune Products segments. Immuron offers Travelan, an over-the-counter medicine and dietary supplement for digestive health, and Protectyn, an immune supplement. The company also develops clinical-stage candidates, including Travelan (IMM-124E) and IMM-529 for gastrointestinal conditions, alongside the pre-clinical IMM-986. Additionally, Immuron provides a technology platform and maintains collaborations for therapeutic development. Immuron Ltd ADR is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Immuron Ltd ADR stock

EBIT per Employee of Immuron Ltd ADR is -579,000.00 USD in 2026.

EBIT per Employee of Immuron Ltd ADR changed from -464,770.29 USD to -579,000.00 USD, representing a 24.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Immuron Ltd ADR since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Immuron Ltd ADR historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Immuron Ltd ADR

All Key Metrics — Immuron Ltd ADR